SNDX
Syndax Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Peter Ordentlich sold $646K of Syndax Pharmaceuticals, Inc.
Sold$646,093
$25.84Price
25,000Shares
−100%Stake
What SNDX did after the filing
- The stock from Fri, Feb 17 close, $26.16
- −20.1%
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Apr 3 close.
Traded Wed, Feb 15. Filed Fri, Feb 17, 1:09 PM ET, during the session. Returns use the Feb 17 close and the Apr 3 close. Not investment advice.